Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study - PubMed (original) (raw)
. 2004 Sep 15;96(18):1358-67.
doi: 10.1093/jnci/djh259.
Affiliations
- PMID: 15367568
- DOI: 10.1093/jnci/djh259
Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study
Arnold L Potosky et al. J Natl Cancer Inst. 2004.
Abstract
Background: Men treated for clinically localized prostate cancer with either radical prostatectomy or external beam radiotherapy usually survive many years with the side effects of these treatments. We present treatment-specific quality-of-life outcomes for prostate cancer patients 5 years after initial diagnosis.
Methods: The cohort consisted of men aged 55-74 years who were newly diagnosed with clinically localized prostate cancer in 1994-1995 and were treated with radical prostatectomy (n = 901) or external beam radiotherapy (n = 286). We used clinical and quality-of-life data previously collected at the time of diagnosis (i.e., baseline) and at the 2-year follow-up and data newly collected at 5 years after diagnosis to compare urinary, bowel, and sexual function and to examine temporal changes in those functions. Odds ratios (ORs) and adjusted percentages were calculated by logistic regression. All statistical tests were two-sided.
Results: At 5 years after diagnosis, overall sexual function declined in both groups to approximately the same level. However, at 5 years after diagnosis, erectile dysfunction was more prevalent in the radical prostatectomy group than in the external beam radiotherapy group (79.3% versus 63.5%; OR = 2.5, 95% confidence interval [CI] = 1.6 to 3.8). Approximately 14%-16% of radical prostatectomy and 4% of external beam radiotherapy patients were incontinent at 5 years (OR = 4.4, 95% CI = 2.2 to 8.6). Bowel urgency and painful hemorrhoids were more common in the external beam radiotherapy group than in the radical prostatectomy group. All of these differences remained statistically significant after adjustment for confounders and for differences between treatment groups in some baseline characteristics.
Conclusions: At 5 years after diagnosis, men treated with radical prostatectomy for localized prostate cancer continue to experience worse urinary incontinence than men treated with external beam radiotherapy. However, the two treatment groups were more similar to each other with respect to overall sexual function, mostly because of a continuing decline in erectile function among the external beam radiotherapy patients between years 2 and 5.
Comment in
- Localized prostate cancer: quality of life meets Whitmore's legacy.
Bermejo C, Kristal AR, Zeliadt SB, Ramsey S, Thompson IM. Bermejo C, et al. J Natl Cancer Inst. 2004 Sep 15;96(18):1348-9. doi: 10.1093/jnci/djh282. J Natl Cancer Inst. 2004. PMID: 15367562 No abstract available.
Similar articles
- Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M, Suárez JF, Guedea F, Fernández P, Macías V, Mariño A, Hervas A, Herruzo I, Ortiz MJ, Villavicencio H, Craven-Bratle J, Garin O, Aguiló F; Multicentric Spanish Group of Clinically Localized Prostate Cancer. Ferrer M, et al. Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):421-32. doi: 10.1016/j.ijrobp.2007.12.024. Epub 2008 Mar 5. Int J Radiat Oncol Biol Phys. 2008. PMID: 18325680 - Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS. Gore JL, et al. J Natl Cancer Inst. 2009 Jun 16;101(12):888-92. doi: 10.1093/jnci/djp114. Epub 2009 Jun 9. J Natl Cancer Inst. 2009. PMID: 19509365 - [Quality of life after radiotherapy for prostate cancer].
Joly F, Degrendel AC, Guizard AV. Joly F, et al. Cancer Radiother. 2010 Oct;14(6-7):519-25. doi: 10.1016/j.canrad.2010.06.015. Epub 2010 Aug 21. Cancer Radiother. 2010. PMID: 20728393 Review. French.
Cited by
- Perioperative infection prevention during inflatable penile prosthesis surgery: a narrative review.
Matthew-Onabanjo AN, Matthew AN, Famati E, Nguyen V, Rogers MJ. Matthew-Onabanjo AN, et al. Transl Androl Urol. 2024 Aug 31;13(8):1628-1640. doi: 10.21037/tau-23-497. Epub 2024 Aug 26. Transl Androl Urol. 2024. PMID: 39280674 Free PMC article. Review. - How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden?
Palmstedt E, Månsson M, Kollberg KS, Carlsson S, Hellström M, Wallström J, Hugosson J, Arnsrud Godtman R. Palmstedt E, et al. BMJ Open. 2024 Aug 17;14(8):e083562. doi: 10.1136/bmjopen-2023-083562. BMJ Open. 2024. PMID: 39153780 Free PMC article. - Development of deep learning-based novel auto-segmentation for the prostatic urethra on planning CT images for prostate cancer radiotherapy.
Takagi H, Takeda K, Kadoya N, Inoue K, Endo S, Takahashi N, Yamamoto T, Umezawa R, Jingu K. Takagi H, et al. Radiol Phys Technol. 2024 Aug 14. doi: 10.1007/s12194-024-00832-8. Online ahead of print. Radiol Phys Technol. 2024. PMID: 39143386 - Long-Term Control With Proton Beam Therapy for Recurrent Prostate Cancer in the Right Perineum Following Intensity-Modulated Radiation Therapy: A Case Report.
Ishikawa Y, Suzuki M, Seto I, Takagawa Y, Murakami M. Ishikawa Y, et al. Cureus. 2024 Apr 16;16(4):e58386. doi: 10.7759/cureus.58386. eCollection 2024 Apr. Cureus. 2024. PMID: 38633140 Free PMC article. - An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study.
Cheng Y, Wu L, Xin J, Ben S, Chen S, Li H, Zhao L, Wang M, Cheng G, Du M. Cheng Y, et al. J Transl Med. 2024 Apr 17;22(1):366. doi: 10.1186/s12967-024-05190-y. J Transl Med. 2024. PMID: 38632662 Free PMC article.
Publication types
MeSH terms
Grants and funding
- N01-PC-67000/PC/NCI NIH HHS/United States
- N01-PC-67005/PC/NCI NIH HHS/United States
- N01-PC-67006/PC/NCI NIH HHS/United States
- N01-PC-67007/PC/NCI NIH HHS/United States
- N01-PC-67009/PC/NCI NIH HHS/United States
- N01-PC-67010/PC/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical